Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Bristol-Myers Squibb Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (NYSE:BMY)


Adjustments to Financial Statements

Advanced level


Adjustments to Current Assets

Bristol-Myers Squibb Co., adjusted current assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current assets
Adjustments
Add: Bad debt allowances
After Adjustment
Adjusted current assets

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).


Adjustments to Total Assets

Bristol-Myers Squibb Co., adjusted total assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Bad debt allowances
Less: Deferred income tax assets, non-current2
After Adjustment
Adjusted total assets

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred income tax assets, non-current. See details »


Adjustments to Current Liabilities

Bristol-Myers Squibb Co., adjusted current liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current liabilities
Adjustments
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale)1
After Adjustment
Adjusted current liabilities

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »


Adjustments to Total Liabilities

Bristol-Myers Squibb Co., adjusted total liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale)2
Less: Deferred income tax liabilities, non-current3
Less: Restructuring liability
After Adjustment
Adjusted total liabilities

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »

3 Deferred income tax liabilities, non-current. See details »


Adjustments to Stockholders’ Equity

Bristol-Myers Squibb Co., adjusted total Bristol-Myers Squibb Company shareholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total Bristol-Myers Squibb Company shareholders’ equity
Adjustments
Less: Deferred tax assets (liabilities), net1
Add: Bad debt allowances
Add: Restructuring liability
Add: Noncontrolling interest
After Adjustment
Adjusted total equity

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Deferred tax assets (liabilities), net. See details »


Adjustments to Capitalization Table

Bristol-Myers Squibb Co., adjusted capitalization table

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Short-term debt obligations
Long-term debt, excluding current portion
Total reported debt
Total Bristol-Myers Squibb Company shareholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Current operating lease liabilities2
Add: Non-current operating lease liabilities3
Adjusted total debt
Adjustments to Equity
Less: Deferred tax assets (liabilities), net4
Add: Bad debt allowances
Add: Restructuring liability
Add: Noncontrolling interest
Adjusted total equity
After Adjustment
Adjusted total capital

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Current operating lease liabilities. See details »

3 Non-current operating lease liabilities. See details »

4 Deferred tax assets (liabilities), net. See details »


Adjustments to Reported Income

Bristol-Myers Squibb Co., adjusted net earnings attributable to BMS

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Net earnings attributable to BMS
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in bad debt allowances
Add: Increase (decrease) in restructuring liability
Add: Other comprehensive income (loss)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
After Adjustment
Adjusted net earnings

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 Deferred income tax expense (benefit). See details »